VIROPHARMA INC
4, 1997-07-10
PHARMACEUTICAL PREPARATIONS
Previous: MOOVIES INC, 8-K, 1997-07-10
Next: VIROPHARMA INC, 4, 1997-07-10



UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).
1. Name and Address of Reporting Person
   SRB Associates IV, L.P. 
   c/o Sevin Rosen Fund IV L.P.
   13455 Noel Road, Suite 1670
   Dallas, TX  75240
2. Issuer Name and Ticker or Trading Symbol
   ViroPharma Incorporated
   VPHM
3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year
   June 1997
5. If Amendment, Date of Original (Month/Year)
   
6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   ( ) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other
   (specify below)
   
7. Individual or Joint/Group Filing (Check Applicable Line)
   ( ) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
Common Stock, par value $.0|06/23/|X   | |22,437            |A  |$1.96 per s|1,258,727          |I     |By Sevin Rosen Fund IV LP("|
02 per share               |97    |    | |                  |   |hare       |                   |      |SRF")(1)                   |
- -----------------------------------------------------------------------------------------------------------------------------------|
Common Stock, par value $.0|      |    | |                  |   |           |6,233              |I     |By Sevin Rosen Bayless Mgmt|
02 per share               |      |    | |                  |   |           |                   |      |.                          |
- -----------------------------------------------------------------------------------------------------------------------------------|
                           |      |    | |                  |   |           |                   |      | Co. ("SRB")(1)            |
- -----------------------------------------------------------------------------------------------------------------------------------|
___________________________________________________________________________________________________________________________________|
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Month       |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
Warrants (right to acq|$1.96(2)|06/23|X   | |2          |D  |Immed|(3)  |Common Stock|22,437 |       |0           |I  |By SRF(1)   |
uire Common Stock)    | per sha|/97  |    | |           |   |.    |     |            |       |       |            |   |            |
                      |re      |     |    | |           |   |     |     |            |       |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
                      |        |     |    | |           |   |     |     |            |       |       |            |   |            |
___________________________________________________________________________________________________________________________________|
</TABLE>
Explanation of Responses:
(1)  All securities are owned by SRF and SRB.  SRB Associates IV L.P. ("SRB 
IV") is general partner of SRF and is 
controlled by officers and a stockholder of SRB.  SRB IV disclaims beneficial 
ownership of such securities except 
to the extent of its pecuniary interest therein, and this report shall not be 
deemed an admission that SRB IV is the 
beneficial owner of such securities for purposes of Section 16 or any other 
purpose.
(2)  The Warrants were exercised on a cashless basis pursuant to the terms of 
the Warrants.
(3)  Upon the earlier of (March 3, 2002 and May 12, 2002, respectively) or the 
consummation of a qualified public 
offering, as described in the 
Warrants.
SIGNATURE OF REPORTING PERSON
/s/ John V. Jaggers, General Partner
DATE
July 10, 1997



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission